1) A prior written permission of the approver is necessary for any kind of use including academic use and for-profit use. 2) In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature (Cancer Sci 2018 109(2):330-339) designated by the DEPOSITOR is requested. 3) In publishing the research results obtained by use of the cell, an acknowledgement is requested.
Nagoya University Graduate School of Medicine Department of Pathology and Biological Responses 65 Tsuruma-Cho, Showa-Ku, Nagoya, Aichi 466-8550
Dr.Ohara, Yuuki
Fax. +81-52-744-2091
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).